A new method to measure renal tubular degradation of small filtered proteins in man using radiolabelled aprotinin (Trasylol)

1. A method has been developed to measure the renal tubular degradation of small filtered proteins in man using radiolabelled aprotinin (Trasylol), a 6500 Da cationic polypeptide. 2. Aprotinin (0.5 or 5.0 mg) was labelled with either 99mTc (40 MBq) or 131I (1 MBq) and injected intravenously in 19 re...

Full description

Saved in:
Bibliographic Details
Published in:Clinical science (1979) Vol. 83; no. 3; p. 289
Main Authors: Rustom, R, Grime, S, Maltby, P, Stockdale, H R, Critchley, M, Bone, J M
Format: Journal Article
Language:English
Published: England 01-09-1992
Subjects:
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract 1. A method has been developed to measure the renal tubular degradation of small filtered proteins in man using radiolabelled aprotinin (Trasylol), a 6500 Da cationic polypeptide. 2. Aprotinin (0.5 or 5.0 mg) was labelled with either 99mTc (40 MBq) or 131I (1 MBq) and injected intravenously in 19 renal patients (10 with normal renal function and nine on haemodialysis). Activity in plasma and urine was measured over 48 h, and chromatography with Sephadex-G-25-M was used to separate labelled aprotinin from free 99mTcO4- or 131I-. Renal uptake was measured for 99mTc-labelled aprotinin only. 3. The volumes of distribution were similar in all patients: 18.2 +/- 0.4 litres in those with normal renal function and 20.2 +/- 0.1 litres in the others. Chromatography showed all plasma activity as undegraded aprotinin and urine activity only as the free labels (99mTcO4- or 131I-). 4. In patients with normal renal function, activity in the kidneys rose rapidly to 24.2 +/- 2.8% of dose after 90 min and to 42.2 +/- 3.4% of dose after 24 h. In the dialysis patients, activity over the kidneys was only 2.7 +/- 0.8% of dose at 24 h. Extra-renal uptake was insignificant in all patients with normal kidney function. 5. Both 99mTcO4- and 131I- appeared in the urine promptly after injection, and the rates of excretion of the two isotopes were similar, varying little over 24 h (1.8 +/- 0.04% of dose/h and 1.7 +/- 0.04% of dose/h for 99mTc and 131I, respectively).
AbstractList 1. A method has been developed to measure the renal tubular degradation of small filtered proteins in man using radiolabelled aprotinin (Trasylol), a 6500 Da cationic polypeptide. 2. Aprotinin (0.5 or 5.0 mg) was labelled with either 99mTc (40 MBq) or 131I (1 MBq) and injected intravenously in 19 renal patients (10 with normal renal function and nine on haemodialysis). Activity in plasma and urine was measured over 48 h, and chromatography with Sephadex-G-25-M was used to separate labelled aprotinin from free 99mTcO4- or 131I-. Renal uptake was measured for 99mTc-labelled aprotinin only. 3. The volumes of distribution were similar in all patients: 18.2 +/- 0.4 litres in those with normal renal function and 20.2 +/- 0.1 litres in the others. Chromatography showed all plasma activity as undegraded aprotinin and urine activity only as the free labels (99mTcO4- or 131I-). 4. In patients with normal renal function, activity in the kidneys rose rapidly to 24.2 +/- 2.8% of dose after 90 min and to 42.2 +/- 3.4% of dose after 24 h. In the dialysis patients, activity over the kidneys was only 2.7 +/- 0.8% of dose at 24 h. Extra-renal uptake was insignificant in all patients with normal kidney function. 5. Both 99mTcO4- and 131I- appeared in the urine promptly after injection, and the rates of excretion of the two isotopes were similar, varying little over 24 h (1.8 +/- 0.04% of dose/h and 1.7 +/- 0.04% of dose/h for 99mTc and 131I, respectively).
Author Grime, S
Bone, J M
Rustom, R
Maltby, P
Stockdale, H R
Critchley, M
Author_xml – sequence: 1
  givenname: R
  surname: Rustom
  fullname: Rustom, R
  organization: Department of Nuclear Medicine, Royal Liverpool University Hospital, U.K
– sequence: 2
  givenname: S
  surname: Grime
  fullname: Grime, S
– sequence: 3
  givenname: P
  surname: Maltby
  fullname: Maltby, P
– sequence: 4
  givenname: H R
  surname: Stockdale
  fullname: Stockdale, H R
– sequence: 5
  givenname: M
  surname: Critchley
  fullname: Critchley, M
– sequence: 6
  givenname: J M
  surname: Bone
  fullname: Bone, J M
BackLink https://www.ncbi.nlm.nih.gov/pubmed/1382914$$D View this record in MEDLINE/PubMed
BookMark eNot0D1PwzAQBmAPRaUtDPwAJI8wBBw7TZyxqviSKrGUuTrbl2Lk2JGdCFXix2NEdcO9w3PvcEsy88EjITcleyhZxR91YlIwLtsZWbCyEsWa8_KSLFP6YoyLPHMyL4XkbVktyM-GevymPY6fwdAx5ARpikgjenB0nNTkIFKDxwgGRhs8DR1NPThHO-tGjGjoEMOI1idqPe3B0ylZf6T5wAYHCp3LBv6Q9Vnc7SOkkwvu_opcdOASXp_3inw8P-23r8Xu_eVtu9kVmvNqLLpaNkYp3elGGgONbsS6raWQTDfIlQHZIWdaINRtZhp1jUZq1daqBJPJitz-9w6T6tEchmh7iKfD-Qv8F9r_YdA
CitedBy_id crossref_primary_10_3109_1061186X_2015_1015537
crossref_primary_10_3109_10717544_2016_1145306
crossref_primary_10_3390_ijms25137209
crossref_primary_10_1517_14740330802510717
crossref_primary_10_1002_path_2148
crossref_primary_10_1016_j_nucmedbio_2005_06_006
crossref_primary_10_1081_JDI_100104734
crossref_primary_10_1093_bja_aem252
crossref_primary_10_3109_00365519609088795
crossref_primary_10_1016_j_athoracsur_2008_04_048
crossref_primary_10_1016_S0041_1345_00_02449_0
crossref_primary_10_1213_ane_0b013e3181a7f00a
crossref_primary_10_1017_S0265021505222287
crossref_primary_10_1017_S0265021505001109
crossref_primary_10_3109_08860229809045124
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1042/cs0830289
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
ExternalDocumentID 1382914
Genre Research Support, Non-U.S. Gov't
Journal Article
Comparative Study
GroupedDBID ---
.55
.GJ
0R~
0VX
29B
2WC
3O-
4.4
53G
5GY
5RE
5VS
6J9
AABGO
AAHRG
ABCQX
ABJNI
ACGFO
ACGFS
ADBBV
AEGXH
AENEX
AFFNX
AFFVI
AI.
AIAGR
AIZAD
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CGR
CS3
CUY
CVF
DU5
E3Z
EBD
EBS
ECM
EIF
EJD
EMOBN
F5P
GX1
H13
HZ~
L7B
MV1
MVM
NPM
NTEUP
O9-
OHT
P2P
P6G
RHI
RPO
SV3
TR2
VH1
WH7
X7M
ZGI
ZXP
ID FETCH-LOGICAL-c224t-f687dbbcfc78dda7c735968380c7e2bda8fe20c3ea69bbccec6ed8cb96b1ad7e2
ISSN 0143-5221
IngestDate Sat Sep 28 08:34:47 EDT 2024
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c224t-f687dbbcfc78dda7c735968380c7e2bda8fe20c3ea69bbccec6ed8cb96b1ad7e2
PMID 1382914
ParticipantIDs pubmed_primary_1382914
PublicationCentury 1900
PublicationDate 1992-Sep
PublicationDateYYYYMMDD 1992-09-01
PublicationDate_xml – month: 09
  year: 1992
  text: 1992-Sep
PublicationDecade 1990
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Clinical science (1979)
PublicationTitleAlternate Clin Sci (Lond)
PublicationYear 1992
SSID ssj0023232
Score 1.4951249
Snippet 1. A method has been developed to measure the renal tubular degradation of small filtered proteins in man using radiolabelled aprotinin (Trasylol), a 6500 Da...
SourceID pubmed
SourceType Index Database
StartPage 289
SubjectTerms Aprotinin - blood
Aprotinin - pharmacokinetics
Aprotinin - urine
Chromatography, Gel
Chromatography, Paper
Humans
Iodine Radioisotopes
Kidney Diseases - metabolism
Kidney Tubules - metabolism
Proteins - metabolism
Renal Dialysis
Technetium
Time Factors
Title A new method to measure renal tubular degradation of small filtered proteins in man using radiolabelled aprotinin (Trasylol)
URI https://www.ncbi.nlm.nih.gov/pubmed/1382914
Volume 83
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV07b9swECbsFi2yFG2aIEkfuKFDgkCoLNoiORqpWy_u0KRAt0B8CDAQPxDbW3587viQrQQpmqGLIJCUYPM-kXfHu-8Y-1IatHtQ881yVYiMKN8yZaoyGyjLcbfObd8zMY0vxc8_8tuoP-p0UtWybdt_lTS2oawpc_YZ0m5eig14jzLHK0odr_8k9yEVCY-FoUmxnAUn4Pmt83HlG-3jTi1xRNhGXVzN6IS6ntLRuSPigAUVwfShsuTj33iHAj4wRUOYTipwTEWDqLoE6ai4463Q8r9JfoVEfdBKuzRene0poXbcD782qH3OWpGLP6jiQMsrO6lu1oEBtMlGu1zjQp6CocfxYRvT-YomPGvr0ORoDIcs6bQih9I2EXl8d3kN5YYeLfu48qBczConNrP2GJTOcuZlTWyLKmSs_rXzAf927OmyLipTpG9fTBqLnhe-Al7zJxJ1Vb_42vyYPfYqvuKB5eI1mKu37E00PWAYMPOOddx8n72exOCK9-xuCAgdCNCB9QIidMBDByJ0YAc6sKjBQwcSdCBBB6ZzQOiAhw60oAMNdOA0AefsgP3-Prq6GGexOEdmUOtbZ3UphdXa1EZIaythBB-oUnKZG-EKbStZuyI33FWlwmHGmdJZabQqda-yOOSQvZgv5u6IgdaUHo62Bm61_dxyaTjOnRjUzvSUluUxOwzzdr0MDCzXcUJPnur4wPa2YPvIXtb4cbtPrLuym89egvecgXD7
link.rule.ids 782
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+new+method+to+measure+renal+tubular+degradation+of+small+filtered+proteins+in+man+using+radiolabelled+aprotinin+%28Trasylol%29&rft.jtitle=Clinical+science+%281979%29&rft.au=Rustom%2C+R&rft.au=Grime%2C+S&rft.au=Maltby%2C+P&rft.au=Stockdale%2C+H+R&rft.date=1992-09-01&rft.issn=0143-5221&rft.volume=83&rft.issue=3&rft.spage=289&rft_id=info:doi/10.1042%2Fcs0830289&rft_id=info%3Apmid%2F1382914&rft_id=info%3Apmid%2F1382914&rft.externalDocID=1382914
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0143-5221&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0143-5221&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0143-5221&client=summon